These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25711460)

  • 1. Discovery of a small-molecule pBcl-2 inhibitor that overcomes pBcl-2-mediated resistance to apoptosis.
    Song T; Yu X; Liu Y; Li X; Chai G; Zhang Z
    Chembiochem; 2015 Mar; 16(5):757-65. PubMed ID: 25711460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding.
    Song T; Chai G; Liu Y; Yu X; Wang Z; Zhang Z
    Br J Pharmacol; 2016 Feb; 173(3):471-83. PubMed ID: 26493374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and Solution NMR Study of Multi-site Phosphomimetic Mutant BCL-2 Protein.
    Song T; Cao K; Fan YD; Zhang Z; Guo ZW; Zhang MH; Liu P
    Protein Pept Lett; 2019 Jul; 26(6):449-457. PubMed ID: 30919764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1.
    Zhang Z; Liu Y; Song T; Xue Z; Shen X; Liang F; Zhao Y; Li Z; Sheng H
    Br J Cancer; 2013 May; 108(9):1870-8. PubMed ID: 23558901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Pérez-Galán P; Roué G; López-Guerra M; Nguyen M; Villamor N; Montserrat E; Shore GC; Campo E; Colomer D
    Leukemia; 2008 Sep; 22(9):1712-20. PubMed ID: 18596739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Bcl-2 inhibitors: Discovery and mechanism study of small organic apoptosis-inducing agents.
    Zhang Z; Jin L; Qian X; Wei M; Wang Y; Wang J; Yang Y; Xu Q; Xu Y; Liu F
    Chembiochem; 2007 Jan; 8(1):113-21. PubMed ID: 17139689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin from Flos Chrysanthemi and its derivatives: New small molecule Bcl-2 protein inhibitors.
    Zheng CH; Zhang M; Chen H; Wang CQ; Zhang MM; Jiang JH; Tian W; Lv JG; Li TJ; Zhu J; Zhou YJ
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4672-4677. PubMed ID: 25193233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH; Zihlif MA; Taha MO
    Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-BH3 mimetic S1 exhibits broad-spectrum antitumour effects by cooperation between Bax and Bak.
    Song T; Xue Z; Zhang Z; Shen X; Li X
    Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):145-51. PubMed ID: 23557083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation.
    Song T; Wang P; Yu X; Wang A; Chai G; Fan Y; Zhang Z
    Br J Pharmacol; 2019 Feb; 176(3):491-504. PubMed ID: 30500985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.
    Konopleva M; Contractor R; Tsao T; Samudio I; Ruvolo PP; Kitada S; Deng X; Zhai D; Shi YX; Sneed T; Verhaegen M; Soengas M; Ruvolo VR; McQueen T; Schober WD; Watt JC; Jiffar T; Ling X; Marini FC; Harris D; Dietrich M; Estrov Z; McCubrey J; May WS; Reed JC; Andreeff M
    Cancer Cell; 2006 Nov; 10(5):375-88. PubMed ID: 17097560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
    Enyedy IJ; Ling Y; Nacro K; Tomita Y; Wu X; Cao Y; Guo R; Li B; Zhu X; Huang Y; Long YQ; Roller PP; Yang D; Wang S
    J Med Chem; 2001 Dec; 44(25):4313-24. PubMed ID: 11728179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics.
    Karlberg M; Ekoff M; Huang DC; Mustonen P; Harvima IT; Nilsson G
    J Immunol; 2010 Aug; 185(4):2555-62. PubMed ID: 20639495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells.
    Zhang M; Ling Y; Yang CY; Liu H; Wang R; Wu X; Ding K; Zhu F; Griffith BN; Mohammad RM; Wang S; Yang D
    Ann Hematol; 2007 Jul; 86(7):471-81. PubMed ID: 17396262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel small molecular BH3 mimetics SM3 and its regulation of cell apoptosis and autophagy.
    Wang Y; Fan S; Li X; Xiaokaiti Y; Pan Y; Tie L; Li X
    Biochem Biophys Res Commun; 2019 Sep; 517(1):15-22. PubMed ID: 31303271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
    Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
    Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.
    Yu L; Liu S
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):553-60. PubMed ID: 24012660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BH3 mimetics inhibit growth of chondrosarcoma--a novel targeted-therapy for candidate models.
    Morii T; Ohtsuka K; Ohnishi H; Mochizuki K; Yoshiyama A; Aoyagi T; Hornicek FJ; Ichimura S
    Anticancer Res; 2014 Nov; 34(11):6423-30. PubMed ID: 25368242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.